| Read this first | BIOVIA ONE Lab is not a mid-market LIMS. It is the lab informatics layer of a comprehensive scientific innovation platform that also covers molecular modelling, formulation design, manufacturing analytics, and regulatory quality management — all connected on a single RDF data model. Labs evaluating ONE Lab are not choosing between it and QBench or CloudLIMS. They are choosing between it and LabWare LIMS, Thermo Fisher SampleManager, or Veeva Vault for quality. The correct buyer profile is a large pharmaceutical, biopharma, CPG, or materials science organisation that needs end-to-end digital integration from molecule to market, not a 20-person contract testing laboratory that needs compliant sample tracking. If your lab fits the latter, other vendors in this series will deliver faster time to value at a fraction of the cost. |
BIOVIA ONE Lab is the laboratory informatics platform of BIOVIA, the scientific innovation brand of Dassault Systèmes. It combines Electronic Lab Notebook (ELN), LIMS, and Laboratory Execution System (LES) functions in a single, unified environment built on one data model — a design choice that separates it structurally from nearly every other LIMS in this series, where ELN, LIMS, and workflow modules are separate products integrated at the API layer.
Dassault Systèmes (Euronext Paris: DSY.PA) is the 3DEXPERIENCE Company, founded in 1981 and best known for CATIA (aerospace engineering) and SOLIDWORKS (industrial design). Its BIOVIA brand was created in May 2014 when Dassault acquired Accelrys, Inc. for $750 million — a company that was itself a fusion of five scientific software firms including Molecular Simulations Inc. and Oxford Molecular. Accelrys brought a 20-year legacy of pharmaceutical and materials science software, including the predecessor products to what is now ONE Lab. BIOVIA is headquartered in San Diego, California, and operates as Dassault Systèmes’ scientific arm alongside the broader 3DEXPERIENCE platform used by 370,000+ companies globally.
More than 2,000 companies across life sciences, chemistry, oil & gas, consumer packaged goods, and other industries use BIOVIA solutions (3ds.com). Named users of the BIOVIA portfolio include Pfizer, AstraZeneca, BASF, Shell, Unilever, and L’Oréal — though these references are to the BIOVIA platform broadly, not confirmed specifically to ONE Lab. The lab informatics layer (ONE Lab) is described as trusted by large pharmaceutical enterprises for standardising and accelerating testing in QA/QC labs (3ds.com/products/biovia/one-lab/les).
This article draws on 3ds.com (ONE Lab, LIMS, LES, ELN, Equipment Management, and AI-ready lab product pages), discover.3ds.com, the Axendia independent analyst briefing on ONE Lab (April 2024), the BIOVIA GxP compliance blog post (3ds.com), Wikipedia (BIOVIA and Dassault Systèmes history), the Dassault Systèmes BIOVIA brand introduction press release (May 2014), the BIOVIA ONE Lab datasheet PDF, G2 (BIOVIA Notebook and CISPro reviews), and a Scispot competitor-authored pricing analysis (November 2025, attributed accordingly). BIOVIA/Dassault Systèmes has not reviewed, sponsored, or paid for this article.
Understanding BIOVIA — the platform context every lab manager needs
The most common mistake in evaluating BIOVIA ONE Lab is treating it as a standalone LIMS. It is not. ONE Lab is one component of the BIOVIA portfolio on the 3DEXPERIENCE platform, which also covers:
- BIOVIA Discovery Studio & Generative Therapeutics Design: Molecular modelling, drug discovery, and generative AI for small molecule and biologic design
- BIOVIA Pipeline Pilot: Data science automation, workflow orchestration, and scientific analytics. Pfizer used Pipeline Pilot to automate data delivery, saving 1.5 hours per experiment and 5–7 hours per week per scientist (3ds.com — vendor-published).
- BIOVIA Materials Studio: Atomistic modelling for materials science (batteries, polymers, catalysts)
- BIOVIA Discoverant: Manufacturing process analytics for quality-by-design and process monitoring
- BIOVIA Quality Management: End-to-end quality management including CAPA, document control, and regulatory compliance for pharma manufacturing
- BIOVIA Formulation Design: AI-powered formulation management for CPG and pharma
All of these products share the same RDF-based data model on the 3DEXPERIENCE platform. This means experimental data captured in ONE Lab is immediately accessible to Pipeline Pilot for analytics, to Discovery Studio for modelling feedback, and to Quality Management for compliance records — without export, transformation, or integration middleware. This “digital thread from R&D to manufacturing” is the architectural proposition that distinguishes BIOVIA from every other vendor in this series.
For lab managers at large pharmaceutical or CPG organisations already using Dassault Systèmes products (CATIA, SOLIDWORKS, Medidata for clinical trials), ONE Lab’s integration into that existing 3DEXPERIENCE infrastructure is a significant consideration. For lab managers at organisations with no existing Dassault footprint, the question is whether the breadth of the platform justifies the implementation complexity and cost relative to a purpose-built LIMS.
| Strategic context for LabOps directors | The Axendia independent analyst briefing on ONE Lab (April 2024) quotes BIOVIA’s Director of Marketing Stephen Hayward: “Elements of ONE Lab can be deployed individually, together, or added over time as part of a company’s digital transformation journey.” This is the correct framing. Organisations do not need to deploy the entire BIOVIA portfolio to benefit from ONE Lab. A pharma QA/QC lab can deploy the LIMS and LES components alone. A biotech R&D group can start with the ELN. The RDF data model means each component’s data is immediately available to future components without migration. The strategic value multiplier, as Hayward describes it, is horizontal and vertical integration as additional components are added over time. |
At a glance
| Field | Details |
| Product | BIOVIA ONE Lab — unified ELN + LIMS + LES on the 3DEXPERIENCE platform |
| Parent company | Dassault Systèmes (Euronext Paris: DSY.PA). Founded 1981. HQ: Vélizy-Villacoublay, France. BIOVIA HQ: San Diego, California, USA. |
| BIOVIA history | BIOVIA brand created May 2014 from acquisition of Accelrys, Inc. for $750M (Wikipedia). Accelrys was itself formed in 2001 from five scientific software companies including Molecular Simulations Inc. and Oxford Molecular. |
| Scale (BIOVIA) | 2,000+ companies use BIOVIA solutions across life sciences, chemistry, oil & gas, CPG, and other industries (3ds.com). Named customer references include Pfizer, AstraZeneca, BASF, Shell, Unilever, L’Oréal, Aboca. |
| ONE Lab scope | ELN + LIMS + LES + Equipment Management + Inventory Management in one platform with a single RDF data model. Removes artificial barriers between traditionally separate systems. |
| ELN options | Three ELNs, all integrated with ONE Lab: BIOVIA Scientific Notebook (cloud-native, knowledge graph architecture), BIOVIA Notebook (established IP-focused ELN), BIOVIA Workbook (research-focused). All available on cloud. |
| Data model | RDF (Resource Description Framework) / knowledge graph architecture. FAIR data (Findable, Accessible, Interoperable, Reusable) by design. 80% reduction in AI data preparation time reported (3ds.com — vendor-published). |
| Deployment | Cloud (BIOVIA ScienceCloud / 3DEXPERIENCE platform — global datacentres, sovereign data control), on-premise, or hybrid. Same code stream across all deployment options (easy migration). Quick Start programme for ELN with pre-packaged configurations. |
| Compliance | FDA 21 CFR Part 11, EU Annex 11, EPA, GxP (GLP, GMP, GCP). 3DEXPERIENCE platform is validation-ready by design. BIOVIA provides Computer System Validation (CSV) kits. Up to 5 validated updates/year on cloud. IMPORTANT: “It is still the responsibility of a customer to validate that their solution is compliant with GxP regulations” (3ds.com/3dexperience/gxp-readiness). |
| CDS integrations | Waters Empower (bidirectional CDS Add-In, confirmed on 3ds.com LIMS and equipment pages). Thermo Fisher Scientific Chromeleon (bidirectional CDS Add-In, same sources). Balances, pH meters, and simple lab equipment (direct result transfer). IoT approach for networked instruments. |
| Integration ecosystem | Waters Empower, Thermo Chromeleon, SAP, iLab, CISPro (chemical inventory). Open APIs for third-party systems. Integration with all BIOVIA portfolio tools (Pipeline Pilot analytics, Discovery Studio modelling, Discoverant manufacturing, Quality Management) via shared data model. |
| Language | English (SourceForge). Dassault Systèmes operates globally with regional offices. |
| Support | Phone support, 24/7 live support, and online (SourceForge confirmed). Dassault Systèmes has global support infrastructure. TECHNIA (certified education partner) provides training. |
| Industries | Life Sciences (pharma, biopharma, biotech), Consumer Packaged Goods, Energy & Materials, Chemical. Confirmed on 3ds.com/products/biovia/one-lab. |
| Pricing | Not publicly published. Packaged as “Roles” on 3DEXPERIENCE platform. Scispot (competitor-authored, November 2025, attributed): ScienceCloud base pricing at £576/user/year, includes support and maintenance, excludes VAT and customisations. Volume discounts available but not published. Implementation via professional services. |
| G2/Capterra | BIOVIA Notebook: G2 profile with limited features, verified reviews. BIOVIA CISPro: G2 reviews. BIOVIA ONE Lab specifically: SourceForge listing, no user reviews submitted. Thin public review base consistent with enterprise buying pattern. |
What BIOVIA ONE Lab does — and why the single data model matters
The foundational architectural decision that separates ONE Lab from all other LIMS in this series is the single RDF data model. In a conventional lab informatics stack, a laboratory deploys an ELN, a LIMS, and sometimes a separate LES. These three systems store data in separate databases and are integrated via APIs that must be built, tested, and maintained. When an experiment in the ELN uses a sample from the LIMS, linking that data requires a query across systems. When results from an instrument feed the LES, those results must be mapped to the LIMS record separately.
In ONE Lab, all of these functions operate on the same underlying data. An experiment record in the ELN, a sample in the LIMS, a procedure in the LES, an instrument metrology event, and an inventory record are all nodes in the same knowledge graph. Relationships between them are native, not constructed. This matters for two specific lab manager concerns:
- Audit trails and compliance: A single data model means the audit trail for any action — who modified a sample, which procedure was executed, which instrument was used, which batch was released — is a native property of the system, not a cross-system reconstruction. The Automated Review-by-Exception (RbE) feature, which enables automatic release of test batches that meet tolerances, relies on this unified data to function reliably.
- AI and analytics readiness: Dassault positions ONE Lab explicitly as producing “AI-ready data from the start.” The RDF model standardises all lab data — across ELN experiments, instruments, inventory, samples, tasks, and procedures — into a clean, searchable format without manual data cleaning. The 3ds.com AI-ready lab page states customers report ONE Lab generates “the highest quality, most reliable generative AI-ready data” within their organisations. This is a vendor claim, but the architectural basis for it — a single data model with agreed taxonomies and ontologies — is structurally sound.
The five functional areas of ONE Lab, all confirmed on 3ds.com product pages:
1. ELN (Electronic Lab Notebook)
Three ELN options integrate with ONE Lab workflows. BIOVIA Scientific Notebook is cloud-native on the 3DEXPERIENCE platform, built on a knowledge graph that connects experimental data across experiments, instruments, and samples with deep searchability. BIOVIA Notebook is the established IP-focused ELN, featuring electronic signatures, audit trails, workflow reminders, and version control for intellectual property protection. BIOVIA Workbook targets research-focused experiment documentation. All three integrate directly with the LIMS and LES, so moving from documentation to task management to sample handling is seamless rather than a system switch.
2. LIMS (Laboratory Information Management System)
The LIMS component manages sample creation, receipt, collection, labelling, splitting, and disposal. Chain of custody is tracked throughout the sample’s lifetime. Sample status, location, and handling history are visible at all times. Integration with the LES means tasks and procedures are linked to the sample record at the point of execution, not linked retrospectively. The LIMS module also handles study management for stability testing: define storage conditions, timepoints, packaging, and test specifications; SLIMS facilitates batch enrolment and pulls together testing plans, results, and trending reports.
3. LES (Laboratory Execution System)
The LES guides analysts through stepwise procedures at the bench. Procedures are built on industry standards including ANSI/ISA88 (process control and recipe management), which means methods created in ONE Lab can be reused from laboratory scale through process development and commercial manufacturing. Only the most current approved SOP is available for data capture; previous versions cannot be used. Automated Review-by-Exception (RbE) automatically releases batches where all results meet pre-configured tolerances, eliminating manual review for passing tests and routing only exceptions to supervisors. The LES also supports mobile device use at the bench.
4. Equipment Management
Instrument data acquisition is handled via an IoT approach for networked instruments and via dedicated CDS Add-Ins for chromatography systems. The two confirmed CDS integrations are bidirectional: Waters Empower and Thermo Fisher Scientific Chromeleon. Both allow direct two-way data exchange with the CDS client — worklists generated from ONE Lab, results returned automatically to test protocols without manual transcription. The equipment registry tracks metrology events including preventative maintenance, calibration schedules, and verification. Instruments can be restricted in ONE Lab to prevent their use in procedures for which they are not qualified.
5. Inventory Management (CISPro)
Chemical and biological inventory is managed through BIOVIA CISPro, which is deeply integrated with ONE Lab (confirmed by a G2 CISPro reviewer: “CISPro integrates so much better with ULM i.e. the ONE Lab suite of BIOVIA”). CISPro handles container-level tracking of chemicals, biologicals, raw materials, and perishables. Chemical usage is automatically tracked when a procedure is executed in ONE Lab, linking consumption to the specific experiment and sample. Safety Data Sheet (SDS) management and regulatory compliance for chemical storage are built in.
Deployment and validation
ONE Lab is available in three deployment configurations, all using the same code stream:
- Cloud (BIOVIA ScienceCloud / 3DEXPERIENCE platform): Hosted on Dassault Systèmes’ global datacentres with sovereign data control by region. Described as “cloud-native SaaS.” Provides up to 5 validated software updates per year using BIOVIA’s Validation Kits. Reduces IT overhead and total cost of ownership. This is the primary deployment model promoted.
- On-premise: Full installation on the customer’s own infrastructure. Available for organisations that require complete end-to-end infrastructure control. Validation is the customer’s responsibility in full.
- Hybrid: Mixed cloud/on-premise. Available for organisations with specific data sovereignty or regulatory requirements that prevent full cloud deployment.
BIOVIA’s approach to Computer System Validation (CSV) is explicitly described on 3ds.com/products/biovia/one-lab and the GxP readiness page. BIOVIA provides validation testing kits and works closely with customers to validate deployments efficiently. For cloud deployments, BIOVIA’s automation performs initial validation steps, delivering production environments “ready for final validation.” For regulated environments, up to five releases per year can be validated using the provided kits.
| Validation caveat for lab managers | The 3DEXPERIENCE GxP readiness page states explicitly: “It is still the responsibility of a customer to validate that their solution is compliant with GxP regulations.” The platform is “validation-ready by design” — meaning built-in features support the validation process — but this is not the same as vendor-validated and vendor-certified as is offered by some competitors. Labs in highly regulated environments should clarify with BIOVIA precisely which validation deliverables are provided, which are the customer’s responsibility, and what the cost and timeline of CSV activities looks like for their specific deployment configuration. |
How ONE Lab compares to other LIMS in this series
The comparison below is for context only. The fundamental point is that ONE Lab operates at a different scale and integration depth than most other vendors in this series. Direct feature-by-feature comparisons at the module level understate the architectural difference.
| Dimension | BIOVIA ONE Lab | Typical mid-market LIMS | Notes |
| Target buyer | Large pharma, biopharma, CPG, materials enterprise | Mid-market analytical, environmental, QC lab | Different market segments |
| Data model | Single RDF data model across ELN+LIMS+LES+Equipment+Inventory | Separate modules integrated via API | ONE Lab’s structural advantage |
| AI readiness | AI-ready data native to the platform architecture | Requires data preparation and cleaning | ONE Lab’s future-facing differentiator |
| Modelling link | Direct connection to Discovery Studio, Pipeline Pilot | Not available | Unique to BIOVIA platform |
| Manufacturing | Connected to Discoverant analytics and Quality Management | Separate QMS typically required | End-to-end digital thread |
| CDS integration | Waters Empower, Thermo Chromeleon (bidirectional, native) | Varies by vendor | Strong if using Waters or Thermo CDS |
| Pricing | £576/user/year base ScienceCloud (competitor estimate, attributed); enterprise contracts | Wide range, some published | BIOVIA is enterprise-tier |
| Implementation | Professional services; months-long for full deployment | Weeks to months depending on platform | Higher complexity, higher reward |
| Review base | Thin public reviews (enterprise buying pattern) | Varies; some have 100+ G2 reviews | Reference calls essential for BIOVIA |
Named customers and user signals
The public evidence base for BIOVIA ONE Lab specifically is smaller than for the broader BIOVIA portfolio. The 2,000+ company customer count and named pharma/CPG references (Pfizer, AstraZeneca, BASF, Unilever, L’Oréal, Aboca) are for BIOVIA solutions broadly, not confirmed specifically for ONE Lab. The following are verifiable signals:
- Enterprise consolidation case study (3ds.com — vendor-published, unnamed): One enterprise customer replaced 5 ELNs and 3 LIMS with ONE Lab, reporting a 60% increase in scientific efficiency. Customer not named.
- R&D cost saving (discover.3ds.com — vendor-published, unnamed): $30 million annual savings reported by an R&D customer using BIOVIA (Pipeline Pilot component). Challenge: manual data mining and 30–40% repetition of experimental work due to absence of knowledge sharing. Solution: BIOVIA-based digital backbone creating a ‘paperless science’ environment.
- Pfizer / Pipeline Pilot (3ds.com — vendor-published, named): Pfizer used BIOVIA Pipeline Pilot to automate data delivery and error checking. Result: 1.5 hours saved per experiment, 5–7 hours saved per week per scientist, reduced transcription errors. This is a Pipeline Pilot reference, not ONE Lab specifically.
- Aboca (3ds.com — vendor-published, named): Aboca (Italian botanical health company) uses BIOVIA to standardise labs, boost efficiency, cut errors, and ensure regulatory compliance. Product specifics not confirmed.
- Axendia independent analyst briefing (April 2024): Axendia (industry analyst firm) was briefed by BIOVIA’s Director of Marketing Stephen Hayward on ONE Lab. Axendia’s write-up describes ONE Lab as a “single data model” environment enabling FAIR data and “end-to-end digital integration.” This is an analyst briefing based on vendor-provided information, not an independent audit.
G2 review signals (for BIOVIA Notebook and CISPro components)
BIOVIA ONE Lab itself has no published G2 or Capterra user reviews as of April 2026. The component products do:
- BIOVIA Notebook (G2, verified): Reviewers describe it as useful for IP protection, data documentation, and integration with CISPro via Pipeline Pilot. Positive: cloud transition resolved earlier data caching issues from the desktop era. Negative: historical pain point was desktop-only installation (since resolved by cloud deployment).
- BIOVIA CISPro (G2, verified): “CISPro integrates so much better with ULM i.e. the ONE Lab suite of BIOVIA” (direct quote). Negative: the old ExtJS 4 design is “not modern looking” and “takes a lot of time to load initially.” This is an acknowledged technical debt issue for legacy components within the platform.
| Review context for lab managers | The absence of ONE Lab-specific public reviews is consistent with enterprise software buying behaviour: large pharma procurement teams do not post reviews on G2. This does not signal low adoption — it signals that the buyer profile for ONE Lab does not intersect with the G2 review demographic. Due diligence for ONE Lab requires direct reference calls with existing customers in your industry and scale, obtainable through BIOVIA’s enterprise sales process. Ask specifically: how long did full implementation take; how was validation handled; what was the total cost in Year 1 versus subsequent years; and what professional services are required for ongoing configuration changes. |
Pricing
BIOVIA does not publish pricing publicly. The platform is sold as enterprise software through Dassault Systèmes’ sales organisation. Solutions are packaged as “Roles” on the 3DEXPERIENCE platform — each Role bundles a set of applications appropriate for a specific user type (e.g., a Laboratory Operations Supervisor Role, a Stability Testing Role, a Chromeleon/Empower Adapter Role).
The only independent pricing signal comes from a Scispot competitor-authored analysis (November 2025, explicitly attributed as competitor-authored): the BIOVIA ScienceCloud base pricing starts at £576 per user per year, which includes product support and maintenance. This figure excludes VAT, client-specific customisations (quoted case-by-case), and implementation services. Volume discounts are available but are not published.
For perspective: £576/user/year (≈ $720/user/year at current rates) is a low base for enterprise software at this complexity level. Professional services for implementation, which are required for any meaningful ONE Lab deployment, are billed separately and can substantially exceed the licence cost in Year 1.
| Total cost of ownership for lab managers | When requesting a BIOVIA ONE Lab quote, labs should ask for: (1) per-user licence costs for each Role selected; (2) implementation professional services estimate (not included in licence); (3) Computer System Validation kit costs and the timeline of validation activities your team will own; (4) annual maintenance and support costs in Year 2 and beyond; (5) costs for configuration changes or new workflow additions after go-live; (6) training costs (BIOVIA-certified training is available via TECHNIA and internally). For large enterprises replacing multiple ELNs and LIMS systems with ONE Lab, the consolidated platform total cost of ownership may compare favourably to maintaining five separate vendor relationships — as the unnamed enterprise case study suggests. |
Who BIOVIA ONE Lab is designed for
The following buyer profiles are confirmed by the platform’s design, the verticals addressed on 3ds.com, and the Axendia analyst briefing:
- Large pharmaceutical and biopharma organisations running R&D, development, and QA/QC across multiple sites and functions, where the value of connecting molecular modelling (Discovery Studio), lab execution (ONE Lab), and manufacturing analytics (Discoverant) on a single data model outweighs the complexity and cost of implementation.
- Organisations that are actively consolidating a fragmented informatics landscape — multiple ELNs, multiple LIMS, disconnected quality management systems — and want a single platform that can replace them progressively rather than in a disruptive rip-and-replace. The modular, additive deployment model (ELN first, LIMS later, LES later) supports this.
- Labs in regulated GxP environments that need validated, compliant data capture from discovery through QA/QC and manufacturing, with a continuous, unbroken digital thread and automated audit trails throughout.
- Organisations that use Waters Empower or Thermo Fisher Chromeleon as their chromatography data system and want native bidirectional integration without custom scripting.
- Consumer packaged goods and materials science companies that need the same rigour as pharma GxP across formulation, quality testing, and manufacturing, particularly those already in the Dassault Systèmes ecosystem via CATIA or SOLIDWORKS.
- Biotech and emerging pharma companies planning for scale, who want to build their informatics infrastructure on a platform that will not require replacement when they grow from research to clinical manufacturing.
BIOVIA ONE Lab is not the right choice for:
- Small to mid-size analytical testing laboratories, environmental labs, water/wastewater utilities, or contract testing facilities that need a compliant LIMS for straightforward sample management and result reporting. QBench, CloudLIMS, LabLynx, or ATL/Confience Sample Master serve those needs at appropriate scale and cost.
- Academic research groups, university labs, or small biotech teams that primarily need an ELN and basic inventory management. eLabFTW (open source, free), Labguru, or SciSure are better positioned for speed, cost, and simplicity.
- Organisations without dedicated scientific informatics or IT capacity to manage implementation and ongoing configuration. ONE Lab implementations require sustained expert involvement in Year 1.
- Labs that need transparent published pricing and self-service sign-up before engaging a vendor. BIOVIA requires an enterprise sales process.
Quick verdict
| Best for | Large pharmaceutical, biopharma, CPG, and materials science organisations that are digitising their laboratories across R&D, development, and QA/QC, and want a single platform with a unified data model connecting ELN, LIMS, LES, equipment management, and inventory — with native links to molecular modelling, manufacturing analytics, and regulatory quality management on the same 3DEXPERIENCE platform. The RDF-based single data model producing FAIR, AI-ready data is a genuine architectural advantage for organisations investing in machine learning and predictive modelling. The Waters Empower and Thermo Chromeleon bidirectional CDS integrations are production-grade for labs running those systems. For organisations already in the Dassault Systèmes ecosystem, ONE Lab is the natural extension into the laboratory. |
| Consider alternatives if | Your lab is mid-size or smaller, does not need the molecular modelling/manufacturing/quality management integration layer, and needs fast deployment and transparent pricing. For mid-market pharma/analytical LIMS, STARLIMS, Sapio Sciences, or SciCord offer GxP-compliant platforms with stronger public review bases and more accessible implementations. For NGS, biobanks, or Agilent instrument-heavy labs, Agilent SLIMS provides a comparable LES architecture. For ELN-first R&D without the enterprise scale, Labguru, Benchling, or eLabFTW are better-matched to the buyer profile and budget. |
Further reading
- BIOVIA ONE Lab official page
- BIOVIA ONE Lab LIMS component
- BIOVIA ONE Lab LES component
- BIOVIA Equipment Management (CDS integrations: Waters Empower, Thermo Chromeleon)
- BIOVIA AI-ready lab (RDF data model and AI readiness)
- BIOVIA GxP compliance in the cloud
- BIOVIA 3DEXPERIENCE GxP readiness (validation responsibility statement)
- Axendia: Integrating Digital Transformation in the Lab — BIOVIA ONE Lab briefing (April 2024)
- Dassault Systèmes introduces BIOVIA — press release (May 2014)
- BIOVIA — Wikipedia (history, Accelrys acquisition)
- BIOVIA CISPro on G2 (inventory component reviews)
- BIOVIA Notebook on G2 (ELN component reviews)
- labsoftwareguide.com: Best LIMS Software 2026
| Editorial note | This article draws on: 3ds.com (ONE Lab product page, LIMS page, LES page, ELN page, Equipment Management page, Inventory Management page, AI-ready lab page, laboratory informatics page, GxP readiness page, 3DEXPERIENCE BIOVIA page, Quality Management page); discover.3ds.com (BIOVIA unified scientific innovation page including R&D $30M saving case study); 3ds.com/about/company/history (BIOVIA brand formation timeline); the Dassault Systèmes BIOVIA brand introduction press release (21 May 2014, 3ds.gcs-web.com); the BIOVIA GxP compliance blog (blog.3ds.com); the BIOVIA ONE Lab datasheet PDF (3ds.com/assets); the BIOVIA Unified Lab Datasheet PDF (paperlesslabacademy.com); Wikipedia (BIOVIA history, Accelrys acquisition for $750M); Axendia independent analyst briefing on ONE Lab (April 2024, axendia.com); G2 (BIOVIA Notebook reviews, BIOVIA CISPro reviews, BIOVIA ONE Lab profile); SourceForge (BIOVIA ONE Lab listing); Scispot competitor-authored pricing analysis (November 2025 — attributed as competitor-authored; Scispot is a LIMS competitor and all pricing figures from this source are attributed accordingly). Named customer references (Pfizer, AstraZeneca, BASF, Shell, Unilever, L’Oréal, Aboca) are for the BIOVIA platform broadly, not confirmed specifically to ONE Lab, and are sourced from 3ds.com/products/biovia/3dexperience-biovia and the Dassault Systèmes brand introduction press release. Efficiency percentages and cost savings in case studies (60% scientific efficiency increase, $30M annual saving) are vendor-published and not independently audited. BIOVIA/Dassault Systèmes has not reviewed, sponsored, or paid for this article. Last verified: April 2026. |


